BRN 2.86% 17.0¢ brainchip holdings ltd

2021 BRN Discussion, page-7890

  1. 9,897 Posts.
    lightbulb Created with Sketch. 26412
    This is of course definitely AKIDA:

    https://www.medicaldevice-network.com/news/brainchip-biotome-antibody-tests/

    BrainChip and Biotomepartner to develop SARS-CoV-2 antibody tests

    06 Apr 2021 (Last Updated April 16th, 2021 14:16)

    Australia-based BrainChip ResearchInstitute and Biotome have entered into a research partnership to developantibody tests for infections such as SARS-CoV-2.

    The Akida processor has theability to learn new sensory data patterns rapidly and categorise the resultsin milliseconds while consuming just microwatts of power. Credit: Marco VerchProfessional Photographer on Flickr.

    Share Article

    Australia-based BrainChipResearch Institute and Biotome have entered into a research partnership todevelop antibody tests for infections such as SARS-CoV-2.

    BrainChip’s Akida neuromorphicprocessor chip will be used to infer sensor responses and to analyse whichresponses are most representative for protective antibodies.

    The research project is aimed atdesigning a handheld device that will deliver precise results in seconds byusing nanomaterial-based sensors and the Akida chip.

    Biotome CEO Dr Samuel Lundinsaid: “Our partnership with BrainChip is an important step for our developmentof point-of-care tests that are based on patented high-precision immunologicalmarkers.

    “The joint project we areembarking on aims to use Akida to identify the antibodies that can protectagainst SARS-CoV-2 infection – the so-called neutralising antibodies.”

    The Akida processor has a majorrole in the development due to its ability to learn new sensory data patternsrapidly and categorise the results in milliseconds while consuming justmicrowatts of power.

    Because the advanced diagnosticequipment works on small batteries, it can be more easily used in remotelocations.

    BrainChip’s Akida chip takesartificial intelligence beyond the edge of what existing technologies arecapable of. A wide range of capabilities are offered by the high-performance,small and ultra-low power solution.

    The Akida neuromorphicsystem-on-chip (NSoC) and intellectual property can be used in Smart Home,Smart Health, Smart City and even Smart Transportation applications. Withinterfaces for ADAS sensors, audio and video sensors, medical sensors and otherIoT sensors, it is designed for usage as a stand-alone embedded processor or asa co-processor

    BrainChip interim CEO Peter vander Made said: “The use of the Akida neuromorphic processor in antibodydetection and other medical diagnostic tools is a testimony to our efforts tohelp in the development of beneficial Artificial Intelligence applicationsaround our chip.”

 
watchlist Created with Sketch. Add BRN (ASX) to my watchlist
(20min delay)
Last
17.0¢
Change
-0.005(2.86%)
Mkt cap ! $333.0M
Open High Low Value Volume
18.0¢ 18.0¢ 16.8¢ $1.174M 6.869M

Buyers (Bids)

No. Vol. Price($)
4 185137 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 920196 12
View Market Depth
Last trade - 16.10pm 13/08/2024 (20 minute delay) ?
BRN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.